Nature Biotechnology, Published online: 20 October 2026; doi:10.1038/s41587-026-03359-y Human Argonaute is repurposed for RNA editing.
ORIGINAL PAPER
Engineered human Argonaute 2 for targeted C-to-U RNA base editing
Engineered human Argonaute 2 for targeted C-to-U RNA base editing
Nature Biotechnology, Published online: 20 October 2026; doi:10.1038/s41587-026-03359-y Human Argonaute is repurposed for RNA editing.
Review the primary source, validate the main result, and establish whether any listed-company transmission is direct.
What the evidence supports so far
Research signals
Classification pending.
What remains unverified
The full methodology, effect size, and limitations still require analyst review.
Company impact remains unverified until a direct economic transmission is established.